Amphastar Pharmaceuticals, Inc. (AMPH)
Stock Price: $20.79 USD
0.10 (0.48%)
Updated Jul 27, 2021 4:00 PM EDT - Market closed
Income Statement (Annual)
Numbers in millions USD. Fiscal year is January - December.
| Year | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 350 | 322 | 295 | 240 | 255 | 252 | 210 | 230 | 204 | 118 | |
| Revenue Growth | 8.53% | 9.4% | 22.69% | -5.87% | 1.45% | 19.51% | -8.37% | 12.41% | 72.63% | - | |
| Cost of Revenue | 207 | 190 | 188 | 150 | 151 | 174 | 159 | 143 | 114 | 90.25 | |
| Gross Profit | 143 | 132 | 107 | 90.51 | 104 | 77.35 | 51.26 | 86.96 | 90.30 | 28.10 | |
| Selling, General & Admin | 65.16 | 63.11 | 58.04 | 50.92 | 47.30 | 46.97 | 40.37 | 36.32 | 31.65 | 30.53 | |
| Research & Development | 67.23 | 68.85 | 57.56 | 43.50 | 41.52 | 37.27 | 28.87 | 33.02 | 31.16 | 31.05 | |
| Other Operating Expenses | 0.00 | 0.00 | 0.00 | -2.64 | 0.00 | 0.00 | 0.00 | 0.13 | 2.09 | 0.07 | |
| Operating Expenses | 132 | 132 | 116 | 91.78 | 88.82 | 84.25 | 69.24 | 69.47 | 64.91 | 61.65 | |
| Operating Income | 10.95 | -0.04 | -8.62 | -1.27 | 15.38 | -6.90 | -17.98 | 17.49 | 25.40 | -33.55 | |
| Interest Expense / Income | 0.37 | 0.12 | 0.24 | 0.83 | 1.02 | 0.99 | 0.61 | 0.96 | 0.78 | 0.58 | |
| Other Expense / Income | 5.64 | -62.82 | 0.14 | -3.34 | -0.28 | 2.48 | -0.44 | -0.70 | -1.27 | -2.24 | |
| Pretax Income | 4.94 | 62.66 | -9.00 | 1.25 | 14.63 | -10.36 | -18.15 | 17.23 | 25.88 | -31.89 | |
| Income Tax | 3.54 | 13.72 | -3.27 | -2.40 | 4.81 | -7.58 | -7.45 | 5.37 | 7.78 | -39.64 | |
| Net Income | 1.40 | 48.94 | -5.74 | 3.65 | 9.82 | -2.79 | -10.70 | 11.86 | 18.09 | 7.75 | |
| Shares Outstanding (Basic) | 47.04 | 46.98 | 46.40 | 46.11 | 45.38 | 44.96 | 41.96 | 38.71 | 38.58 | 38.51 | |
| Shares Outstanding (Diluted) | 49.12 | 49.91 | 46.40 | 48.37 | 47.50 | 44.96 | 41.96 | 38.88 | 38.94 | 38.92 | |
| Shares Change | 0.12% | 1.27% | 0.62% | 1.61% | 0.92% | 7.16% | 8.38% | 0.34% | 0.17% | - | |
| EPS (Basic) | 0.03 | 1.04 | -0.12 | 0.08 | 0.22 | -0.06 | -0.25 | 0.31 | 0.47 | 0.20 | |
| EPS (Diluted) | 0.03 | 0.98 | -0.12 | 0.08 | 0.21 | -0.06 | -0.25 | 0.31 | 0.46 | 0.20 | |
| EPS Growth | -96.94% | - | - | -61.9% | - | - | - | -32.61% | 130% | - | |
| Free Cash Flow Per Share | 0.50 | - | -0.18 | 0.09 | 0.38 | -0.12 | 0.01 | 0.33 | -0.66 | 0.22 | |
| Gross Margin | 41% | 40.9% | 36.3% | 37.7% | 40.8% | 30.8% | 24.4% | 37.9% | 44.2% | 23.7% | |
| Operating Margin | 3.1% | 0.0% | -2.9% | -0.5% | 6.0% | -2.7% | -8.5% | 7.6% | 12.4% | -28.3% | |
| Profit Margin | 0.4% | 15.2% | -1.9% | 1.5% | 3.8% | -1.1% | -5.1% | 5.2% | 8.9% | 6.5% | |
| FCF Margin | 6.7% | 0.1% | -2.8% | 1.7% | 6.7% | -2.1% | 0.3% | 5.5% | -12.4% | 7.1% | |
| Effective Tax Rate | 71.6% | 21.9% | - | - | 32.9% | - | - | 31.1% | 30.1% | - | |
| EBITDA | 25.81 | 79.85 | 5.77 | 15.03 | 27.82 | 1.94 | -5.01 | 29.36 | 36.32 | -22.00 | |
| EBITDA Margin | 7.4% | 24.8% | 2% | 6.3% | 10.9% | 0.8% | -2.4% | 12.8% | 17.8% | -18.6% | |
| EBIT | 5.32 | 62.78 | -8.76 | 2.08 | 15.65 | -9.38 | -17.54 | 18.19 | 26.66 | -31.30 | |
| EBIT Margin | 1.5% | 19.5% | -3.0% | 0.9% | 6.1% | -3.7% | -8.3% | 7.9% | 13.0% | -26.4% |